Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fey

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 25, 2011
The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administrationAndrew B Norman, Michael R Tabet, Mantana K Norman, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1981
Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarityD M Follette, K Fey, G D Buckberg, et al.
Artificial Organs|April 10, 2002
Second-generation microstimulatorIsabel Arcos, R Davis, K Fey, et al.
Chemical Communications (Cambridge, England)|August 12, 2009
A simple one-pot route to mesoporous silicas SBA-15 functionalized with exceptionally high loadings of pendant carboxylic acid groupsChung-Ta Tsai, Yu-Chi Pan, Chun-Chiang Ting, et al.
Pneumologie (Stuttgart, Germany)|July 16, 2010
[Species-specific comparison of upper airways]P Reinhold, S Grützenmache, R Pabst, et al.
Cancer Research|September 29, 2019
Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor ResponseGrace H McGregor, Andrew D Campbell, Sigrid K Fey, et al.
Nature Communications|January 3, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivoArafath K Najumudeen, Sigrid K Fey, Laura M Millett, et al.
Cancer Research|October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK InhibitionSigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Nature|July 1, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancerNuria Vaquero-Siguero, Nikolaos Georgakopoulos, Maria C Puschhof, et al.
Nature Communications|January 5, 2021
A RAC-GEF network critical for early intestinal tumourigenesisK A Pickering, K Gilroy, J W Cassidy, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|May 25, 2011
The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administrationAndrew B Norman, Michael R Tabet, Mantana K Norman, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1981
Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarityD M Follette, K Fey, G D Buckberg, et al.
Artificial Organs|April 10, 2002
Second-generation microstimulatorIsabel Arcos, R Davis, K Fey, et al.
Chemical Communications (Cambridge, England)|August 12, 2009
A simple one-pot route to mesoporous silicas SBA-15 functionalized with exceptionally high loadings of pendant carboxylic acid groupsChung-Ta Tsai, Yu-Chi Pan, Chun-Chiang Ting, et al.
Pneumologie (Stuttgart, Germany)|July 16, 2010
[Species-specific comparison of upper airways]P Reinhold, S Grützenmache, R Pabst, et al.
Cancer Research|September 29, 2019
Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor ResponseGrace H McGregor, Andrew D Campbell, Sigrid K Fey, et al.
Nature Communications|January 3, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivoArafath K Najumudeen, Sigrid K Fey, Laura M Millett, et al.
Cancer Research|October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK InhibitionSigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Nature|July 1, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancerNuria Vaquero-Siguero, Nikolaos Georgakopoulos, Maria C Puschhof, et al.
Nature Communications|January 5, 2021
A RAC-GEF network critical for early intestinal tumourigenesisK A Pickering, K Gilroy, J W Cassidy, et al.
Pageof 6